Quetiapine
Quetiapine is an atypical antipsychotic medicine used to treat schizophrenia, bipolar disorder, and, in some cases, major depressive disorder as an adjunct to antidepressant therapy. It works by modulating dopamine and serotonin receptor activity in the brain, helping manage symptoms such as hallucinations, delusions, mood instability, and depression. It is available as immediate-release and extended-release oral tablets, with dosage determined by the condition and individual response. Common side effects include drowsiness, dizziness, dry mouth, constipation, and weight gain. Important risks include metabolic changes such as increased blood glucose and cholesterol, low blood pressure, movement disorders, and, rarely, neuroleptic malignant syndrome. Treatment requires medical supervision and monitoring of weight, blood glucose, lipid levels, and mental health symptoms; it should not be discontinued abruptly without professional guidance.
Quetiapine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Quetiapine, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Quetiapine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Quetiapine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
